title: Canavanine-induced longevity in mice may require diets with greater than 15.7% protein.
abstract: BACKGROUND: Dietary administration of 1% canavanine had been shown to improve survival in female BALB/c mice consuming diets containing 23.4% protein (dry matter basis). METHODS: In order to determine if this effect also obtains at more moderate dietary protein concentrations, 30 female BALB/c mice were fed a basal diet with 14% protein (15.7% dry matter basis) and another 30 were fed the same diet plus 1% canavanine. RESULTS: Neither mean (Control 873.2 d, Canavanine 870.0 d; SEM = 34.2 d; P = 0.949 from ANOVA) nor median (Control 902 d, Canavanine 884.5 d; P = 0.9058 from Mann-Whitney) lifespans differed between groups.Although mean antinuclear antibody (ANA) titers did not differ between control and canavanine-treated mice at 833 days of age (19.84 vs 20.39 respectively; SEM = 2.64; P = 0.889 from ANOVA), one canavanine-treated mouse displayed an outlying ANA value of 50 (next lower value = 30) denoting possible early sign of incipient autoimmune disease in that individual. CONCLUSION: There may be an interaction between dietary protein level and canavanine with respect to lifespan in mice.
authors.affiliation: Animal Science Department, Cornell University, 320 Morrison Hall, Ithaca, NY 14853 USA. dlb20@cornell.edu.
authors.forename: Dan L
authors.initials: DL
authors.lastname: Brown
references.citation: Toxicol Appl Pharmacol. 1987 Dec;91(3):395-405
references.pmid: 2447682
references.citation: Can J Physiol Pharmacol. 1985 Jul;63(7):843-54
references.pmid: 3876146
references.citation: Eur J Pharmacol. 1994 Feb 15;266(3):269-75
references.pmid: 7513645
references.citation: Biochem Biophys Res Commun. 1994 Jan 14;198(1):206-12
references.pmid: 7507318
references.citation: J Gerontol. 1976 Mar;31(2):144-8
references.pmid: 1249402
references.citation: Mech Ageing Dev. 1988 Apr;43(1):79-98
references.pmid: 3374178
references.citation: J Biol Chem. 1982 Jan 25;257(2):832-8
references.pmid: 6274867
references.citation: Toxicol Appl Pharmacol. 1987 Dec;91(3):406-14
references.pmid: 3424373
references.citation: Immunol Lett. 1988 Aug;18(4):281-7
references.pmid: 2972610
references.citation: Rheum Dis Clin North Am. 1991 May;17(2):323-32
references.pmid: 1862241
references.citation: J Nutr. 1993 Feb;123(2):269-74
references.pmid: 8429371
references.citation: Anal Biochem. 1977 Jan;77(1):147-51
references.pmid: 831568
references.citation: Nutrition. 1989 May-Jun;5(3):155-71; discussion 172
references.pmid: 2520283
references.citation: J Biol Chem. 1989 Aug 15;264(23):13693-6
references.pmid: 2760038
references.citation: Science. 1982 Apr 23;216(4544):415-7
references.pmid: 7071589
references.citation: J Gerontol. 1966 Jul;21(3):404-9
references.pmid: 5944803
references.citation: Eur J Pharmacol. 1992 Jan 21;210(3):343-6
references.pmid: 1612105